DANA FREE: Open Payments
NPI 1164855136 · NORTHPORT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,392 in 67 payments from 13 companies in 2025. Trend: 2023 $930 · 2024 $1,065 · 2025 $1,392
Food & beverage: $1,392
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $451 |
| AstraZeneca Pharmaceuticals LP | 13 | $312 |
| Novo Nordisk Inc | 7 | $191 |
| Otsuka America Pharmaceutical, Inc. | 7 | $171 |
| Lilly USA, LLC | 3 | $53 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Corcept Therapeutics | 2 | $47 |
| UCB, Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Medline Industries LP | 1 | $22 |
Products named: VRAYLAR, REXULTI, Wegovy, AIRSUPRA, FARXIGA, BREZTRI, UBRELVY, Ozempic.
Industry payments across AL — which companies pay providers there.
